Acrylamide in food: what brands need to know

Acrylamide is a process contaminant that can form when plant-based foods rich in carbohydrates are cooked at high heat. It is not usually added as an ingredient. It forms during the same browning chemistry that gives fried, roasted, baked, and toasted foods their color and flavor.

For consumers, acrylamide is often a cancer-risk question. For food brands and manufacturers, it is also a product-quality and process-control question. A result on a lab report only becomes useful when the team knows why acrylamide may have formed, whether the product category is a priority, what market or customer requirements apply, and what changes could reduce levels without damaging food safety or product quality.

The right posture is practical, not alarmist. Regulators and cancer authorities treat acrylamide as a contaminant worth reducing, largely because of animal and mechanistic evidence. At the same time, human dietary studies have not shown a simple, consistent cancer link. Brands should use testing and controls to reduce avoidable exposure, support retailer and regulatory conversations, and keep clear records of the decisions behind each product.

How acrylamide forms

In foods, acrylamide forms mainly when the amino acid asparagine reacts with reducing sugars during high-temperature cooking. That reaction is part of the Maillard reaction, the browning chemistry behind toasted bread, roasted coffee, potato chips, fries, crackers, and many baked cereal products.

The conditions matter. Acrylamide is most associated with:

• plant-based, carbohydrate-rich ingredients
• frying, roasting, baking, toasting, or other dry-heat processing
• higher temperatures and longer cook times
• lower-moisture surfaces where browning is concentrated
• formulas or raw materials with more asparagine or reducing sugars

Boiling and steaming generally produce little or no acrylamide because they do not create the same dry, high-temperature browning environment. That is why two products made from similar ingredients can have very different acrylamide profiles if one is boiled and the other is fried, baked, or roasted.

Acrylamide also has industrial uses outside food, including in the production of polyacrylamide materials. That can create confusion in search results and safety data sheets. For food and supplement brands, the practical issue is usually not industrial acrylamide added to the product. It is acrylamide formed during ingredient processing or finished-product manufacturing.

Foods and processes most likely to contain acrylamide

Acrylamide risk is not spread evenly across the food supply. It is highest in products where plant-based ingredients are browned under dry heat. Product formulation matters, but process history often matters more.

This is why acrylamide should be scoped by product, not by panic. A raw, refrigerated product and a dark-baked grain snack do not carry the same formation logic. A supplement capsule made from non-heat-processed minerals does not raise the same questions as a roasted plant powder or a nutrition bar with baked inclusions.

What the health-risk evidence means

Acrylamide deserves careful language. The strongest agencies do not dismiss it, but they also do not say normal dietary exposure has been proven to cause cancer in humans.

The concern starts with toxicology. High doses of acrylamide have caused cancer in laboratory animals, and acrylamide is converted in the body to glycidamide, a compound that can damage DNA. The International Agency for Research on Cancer classifies acrylamide as probably carcinogenic to humans, and the National Toxicology Program lists it as reasonably anticipated to be a human carcinogen.

The human dietary evidence is less direct. The National Cancer Institute notes that many epidemiologic studies have not found consistent evidence that dietary acrylamide exposure is associated with cancer risk in people. The FDA uses similar caution: animal studies involved much higher levels than those found in human food, and the exact human risk is not fully clear.

For brands, that uncertainty is not a reason to ignore acrylamide. It is a reason to manage it proportionately. The goal is to reduce avoidable formation, especially in product categories where acrylamide is expected, monitored, or commercially sensitive.

The regulatory picture for food brands

In the United States, the FDA monitors acrylamide and has issued guidance to help the food industry reduce levels. That guidance is important, but it is not the same as a national pass/fail limit. FDA guidance for acrylamide in foods is nonbinding and does not set a specific maximum level or action level for all foods.

In the European Union, the regulatory framework is more prescriptive for certain categories. The European Commission describes rules requiring affected food businesses to apply mitigation measures and monitor their effectiveness against benchmark levels. For brands selling into Europe, acrylamide may need to be handled as part of a documented process-control program, not just a one-off lab result.

California adds another layer. Acrylamide is a Proposition 65-listed chemical, and it often appears in California risk reviews. But food-warning enforcement around dietary acrylamide is legally nuanced after a 2025 federal injunction. Brands should not treat acrylamide as a simple label-copy question. When California exposure decisions matter, use a qualified legal or toxicology review and connect the lab result to a defensible exposure framework. Our Prop 65 testing guide explains that broader warning/no-warning decision process.

The practical takeaway: regulation does not give every brand one universal number to chase. It gives teams a reason to scope the product carefully, test when the result will inform a decision, and keep records that explain the decision later.

When brands should consider acrylamide testing

Acrylamide testing is most useful when the product, process, customer, or market makes the result actionable. It is not a default panel for every food or supplement.

Brands usually have a stronger reason to test when:

• a product is fried, baked, toasted, roasted, or otherwise browned under dry heat
• the formula uses potato, cereal, grain, coffee, roasted botanicals, or other heat-processed plant ingredients
• a new ingredient source, process, cook target, or manufacturer changes the formation risk
• a retailer, distributor, or enterprise customer asks for contaminant documentation
• the product is sold in a market where acrylamide mitigation or benchmark levels are relevant
• the team is validating a mitigation step such as changed time, temperature, color target, or ingredient treatment
• California compliance, warning, or exposure assessment is part of a broader review
• the brand needs trend data across lots, suppliers, or production sites

The best test plan starts with the product story. What ingredient or process could create acrylamide? Which lot or production condition is most representative? What decision will the result support? Without those answers, testing can create a number without a clear next step.

What a practical acrylamide testing workflow looks like

A strong acrylamide workflow is built around decisions, not just analysis.

1. Scope the product risk. Review the ingredient list, supplier documents, processing conditions, color targets, moisture, packaging claims, and markets where the product will be sold.
2. Choose the right sample plan. Acrylamide can vary between lots and even between similarly prepared products. Sampling should match the decision: launch release, supplier qualification, market review, or mitigation validation.
3. Use a fit-for-purpose method. FDA has described LC-MS/MS detection and quantitation for acrylamide in foods. Commercial methods commonly report in parts per billion or ug/kg. The method should be appropriate for the matrix and the expected decision limit.
4. Interpret the result in context. A number by itself is not a compliance decision. The team needs to compare it with the relevant market framework, customer spec, internal action limit, exposure assessment, or mitigation target.
5. Decide what changes, if anything. The next step may be no action, more sampling, supplier follow-up, process adjustment, reformulation, new cook targets, or retesting.
6. Preserve the record. Keep the result, method, lot context, assumptions, threshold or benchmark used, and decision rationale in one place.

That final step matters more than most teams expect. If a customer asks why a product was released, or a supplier change affects acrylamide later, the strength of the program depends on whether the team can reconstruct the decision quickly.

How brands reduce acrylamide after testing

Reduction is usually a process-control problem. A clean lab report can be useful, but the stronger program is one that understands which variables caused the result and how to keep future lots under control.

Common reduction levers include:

• Raw-material control. Choose ingredient varieties and suppliers with lower acrylamide precursors when practical, especially reducing sugars and asparagine.
• Storage and handling. For potato products, storage temperature, bruising, sprouting, and reconditioning can affect reducing sugars before cooking.
• Pre-treatment. Blanching, soaking, rinsing, or enzyme-based approaches such as asparaginase may reduce precursors in certain matrices.
• Time and temperature control. Lower peak temperatures, shorter cook times, adjusted roast profiles, and tighter oven/fryer control can reduce formation.
• Color and moisture targets. Darker browning often correlates with higher acrylamide. Lighter color targets and higher final moisture can help when they still meet food-safety and product-quality needs.
• Finished-product monitoring. Periodic testing can confirm whether process changes are holding across lots, suppliers, and production sites.

The caution is that acrylamide reduction should not be treated in isolation. FDA and Codex guidance both emphasize that mitigation has tradeoffs. A lower acrylamide result is not a win if the change compromises microbiological safety, shelf life, nutrition, consumer acceptance, or another chemical-safety control.

How Light Labs helps teams manage acrylamide risk

Acrylamide is a good example of why contaminant work needs both lab quality and workflow discipline.

Light Labs combines an ISO 17025-accredited lab with a software and compliance workflow for brands and manufacturers that need clearer testing records. For acrylamide and other process contaminants, that means teams can connect the analytical result to the product, lot, supplier, action limit, retest, and release decision instead of leaving the answer buried in a PDF or spreadsheet.

Teams can use the Light Labs testing menu to scope relevant contaminant work, then keep results, certificates of analysis, and follow-up actions organized across products. That matters when acrylamide is part of a larger quality program that also includes heavy metals, pesticide residues, mycotoxins, microbiology, packaging-related concerns, or retailer-specific documentation.

The goal is not to make acrylamide more complicated than it needs to be. The goal is to make the decision easier to defend: what was tested, why it was tested, what the result meant, and what the team did next.

Final takeaway

Acrylamide testing works best when it answers a specific decision, not when it is treated as a generic pass/fail panel.

For food and supplement teams, the strongest program is simple to explain:

• identify whether the product and process can plausibly form acrylamide
• test the right matrix with a method that fits the decision
• connect the result to a documented action, limit, customer request, or market requirement

That keeps the work proportionate, defensible, and easier to repeat when ingredients, processes, suppliers, or markets change.